serw-MX  [xml]  
 


    
 DeCS Categories

D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.054 Androstanes .
D04.210.500.054.079 Androstenes .
D04.210.500.054.079.429 Androstenols .
D04.210.500.054.079.429.824 Testosterone .
D04.210.500.054.079.429.824.664 Methyltestosterone .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.169 Antineoplastic Agents, Hormonal .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Methyltestosterone .
17 beta Methyltestosterone .
17 beta-Hydroxy-17-methyl-4-androsten-3-one .
17 beta-Methyltestosterone .
17-Epimethyltestosterone .
17-alpha-Methyltestosterone .
17alpha-Methyl-Testosterone .
17alpha-Methyltestosterone .
17beta-Hydroxy-17-methyl-4-androsten-3-one .
17beta-Methyltestosterone .
Android .
Android-10 .
Android-25 .
Android-5 .
Mesteron .
Mesterone .
Metandren .
Methitest .
Oreton .
Testoviron .
Testred .
Virilon .
17 Epimethyltestosterone .
17 alpha Methyltestosterone .
17 beta Hydroxy 17 methyl 4 androsten 3 one .
17alpha Methyl Testosterone .
17alpha Methyltestosterone .
17beta Hydroxy 17 methyl 4 androsten 3 one .
17beta Methyltestosterone .
Android 10 .
Android 25 .
Android 5 .
A synthetic hormone used for androgen replacement therapy and as an hormonal antineoplastic agent (ANTINEOPLASTIC AGENTS, HORMONAL). .
1.00
31007
 
Antineoplastic Agents, Hormonal .
Antineoplastic Drugs, Hormonal .
Antineoplastic Hormonal Agents .
Antineoplastic Hormonal Drugs .
Antineoplastics, Hormonal .
Hormonal Agents, Antineoplastic .
Hormonal Antineoplastic Drugs .
Hormonal Antineoplastics .
Agents, Antineoplastic Hormonal .
Drugs, Antineoplastic Hormonal .
Hormonal Drugs, Antineoplastic .
Hormonal Antineoplastic Agents .
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) .
0.81
8514736